ACTA OBSTET GYN SCAN 润色咨询

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

出版年份:1926 年文章数:2491 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:5.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2157230, encodeId=84e7215e2302c, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:3.22 投稿<br>6.13 大修<br>7.12 返修<br>7.20 大修<br>7.31 返修<br>8.10 大修<br>9.6 返修<br>9.9 小修<br>9.12 返修<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I4eex9tfQlPnDwV6Vtk58iaOrWVYVM62opN9yV2YbYHBfDialLcFgX8PymKecjib6NmgaHLcLs7vqRxIvZcd2ACiaA/132, createdBy=27552068432, createdName=kphysiotherapy, createdTime=Tue Sep 12 01:41:04 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1215517, encodeId=8c8a121551e42, content=审稿速度:2.0<br>经验分享:1/3月投稿,11/4大修,送外审中,比想象快一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Fri Apr 29 08:27:09 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127026, encodeId=240c212e02666, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:22.10.24投稿<br>一审2个审稿人;<br>分开两次送审;Awaiting initial access, with editor, under review;然后Awaiting initial access 再under review<br>22.12.28 大修<br>23.01.15 修回<br>23.04.04 Reject<br>一审编辑意见很积极,二审送的第3个独立的审稿人,最终被拒了。<br>审稿速度很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad912474377, createdName=12444cf9m16暂无昵称, createdTime=Wed Apr 19 14:50:34 CST 2023, time=2023-04-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1086043, encodeId=213c108604359, content=我为什么投了一个月/很长时间都没有消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220017, encodeId=cc4a122001e8a, content=投了快一个月了,催了两次,还在awaiting initial assessment,真是醉了......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbed2417119, createdName=1238add5m95(暂无昵称), createdTime=Mon May 16 14:14:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118326, encodeId=d132211832609, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:体验还行 历时4个多月 第一轮大修 第二轮小修 终于接收 编辑很友好 审稿人也很nice 不故意刁难 很感谢各方对我的帮助和宽容 这对我很重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Wed Mar 08 20:01:10 CST 2023, time=2023-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=509382, encodeId=63c250938245, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:SCI(2014):2.005 这个杂志实在是太慢了,急着毕业的同学们不要选择此杂志啊!刚中了一篇,跟大家分享一下进度吧! <br> 2014.2.12 投稿 <br> 2014.5月中旬催稿 <br> 2014.5.23 大修 <br> 2014.7.8 修回投稿 <br> 2014.9月初催稿 <br> 2014.9.19 小修 <br> 2014.9.22修回投稿 <br> 中间催稿2次 <br> 2014.12.1小修 <br> 2014.12.4修回投稿 <br> 2014.12.18接收 <br> 整个流程下来催稿催的好心酸啊!每次都是写给主编,副主编和责任编辑,主编很nice,会催下面的人,但是副主编回复都是应付事的,根本没什么作为,这个责任编辑就干脆不回复,最后主编告诉我说他和责任编辑沟通有点不畅,幸好最后接收了,但过程真心折磨人!催稿信一共写过6封!!!慎重啊!伙伴们!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a351612837, createdName=flair, createdTime=Mon Jan 26 14:58:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086044, encodeId=c2bc10860444b, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563036, encodeId=5c3a56303626, content=审稿速度:1.0<br>经验分享:一个Cohort,06-Aug-2018提交,30-Aug-2018 first decision Major Revision 改了将近两个月,在截止前 27-Oct-2018提交大修稿。 Accept 06-Nov-2018 人生第一篇SCI 两年多的心血,虽然分数不高,但是终于处女作要发表了。 AOGS给我印象挺好的,效率比之前评论高多了,而且态度很好很nice 看好这本杂志IF明年上3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/639d16c47afb4a52b6e1f3983790d196/154a00ea32344dbead810d8f723d8666.jpg, createdBy=eb382225597, createdName=12111381m06暂无昵称, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539944, encodeId=cef85399447f, content=有所上涨,看好未来,大家认为呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2023-09-12 kphysiotherapy 来自福建省

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享:3.22 投稿
    6.13 大修
    7.12 返修
    7.20 大修
    7.31 返修
    8.10 大修
    9.6 返修
    9.9 小修
    9.12 返修
    等待中。。。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2157230, encodeId=84e7215e2302c, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:3.22 投稿<br>6.13 大修<br>7.12 返修<br>7.20 大修<br>7.31 返修<br>8.10 大修<br>9.6 返修<br>9.9 小修<br>9.12 返修<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I4eex9tfQlPnDwV6Vtk58iaOrWVYVM62opN9yV2YbYHBfDialLcFgX8PymKecjib6NmgaHLcLs7vqRxIvZcd2ACiaA/132, createdBy=27552068432, createdName=kphysiotherapy, createdTime=Tue Sep 12 01:41:04 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1215517, encodeId=8c8a121551e42, content=审稿速度:2.0<br>经验分享:1/3月投稿,11/4大修,送外审中,比想象快一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Fri Apr 29 08:27:09 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127026, encodeId=240c212e02666, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:22.10.24投稿<br>一审2个审稿人;<br>分开两次送审;Awaiting initial access, with editor, under review;然后Awaiting initial access 再under review<br>22.12.28 大修<br>23.01.15 修回<br>23.04.04 Reject<br>一审编辑意见很积极,二审送的第3个独立的审稿人,最终被拒了。<br>审稿速度很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad912474377, createdName=12444cf9m16暂无昵称, createdTime=Wed Apr 19 14:50:34 CST 2023, time=2023-04-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1086043, encodeId=213c108604359, content=我为什么投了一个月/很长时间都没有消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220017, encodeId=cc4a122001e8a, content=投了快一个月了,催了两次,还在awaiting initial assessment,真是醉了......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbed2417119, createdName=1238add5m95(暂无昵称), createdTime=Mon May 16 14:14:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118326, encodeId=d132211832609, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:体验还行 历时4个多月 第一轮大修 第二轮小修 终于接收 编辑很友好 审稿人也很nice 不故意刁难 很感谢各方对我的帮助和宽容 这对我很重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Wed Mar 08 20:01:10 CST 2023, time=2023-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=509382, encodeId=63c250938245, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:SCI(2014):2.005 这个杂志实在是太慢了,急着毕业的同学们不要选择此杂志啊!刚中了一篇,跟大家分享一下进度吧! <br> 2014.2.12 投稿 <br> 2014.5月中旬催稿 <br> 2014.5.23 大修 <br> 2014.7.8 修回投稿 <br> 2014.9月初催稿 <br> 2014.9.19 小修 <br> 2014.9.22修回投稿 <br> 中间催稿2次 <br> 2014.12.1小修 <br> 2014.12.4修回投稿 <br> 2014.12.18接收 <br> 整个流程下来催稿催的好心酸啊!每次都是写给主编,副主编和责任编辑,主编很nice,会催下面的人,但是副主编回复都是应付事的,根本没什么作为,这个责任编辑就干脆不回复,最后主编告诉我说他和责任编辑沟通有点不畅,幸好最后接收了,但过程真心折磨人!催稿信一共写过6封!!!慎重啊!伙伴们!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a351612837, createdName=flair, createdTime=Mon Jan 26 14:58:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086044, encodeId=c2bc10860444b, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563036, encodeId=5c3a56303626, content=审稿速度:1.0<br>经验分享:一个Cohort,06-Aug-2018提交,30-Aug-2018 first decision Major Revision 改了将近两个月,在截止前 27-Oct-2018提交大修稿。 Accept 06-Nov-2018 人生第一篇SCI 两年多的心血,虽然分数不高,但是终于处女作要发表了。 AOGS给我印象挺好的,效率比之前评论高多了,而且态度很好很nice 看好这本杂志IF明年上3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/639d16c47afb4a52b6e1f3983790d196/154a00ea32344dbead810d8f723d8666.jpg, createdBy=eb382225597, createdName=12111381m06暂无昵称, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539944, encodeId=cef85399447f, content=有所上涨,看好未来,大家认为呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2022-04-29 pinger3557219

    审稿速度:2.0
    经验分享:1/3月投稿,11/4大修,送外审中,比想象快一点

    6

    展开6条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2157230, encodeId=84e7215e2302c, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:3.22 投稿<br>6.13 大修<br>7.12 返修<br>7.20 大修<br>7.31 返修<br>8.10 大修<br>9.6 返修<br>9.9 小修<br>9.12 返修<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I4eex9tfQlPnDwV6Vtk58iaOrWVYVM62opN9yV2YbYHBfDialLcFgX8PymKecjib6NmgaHLcLs7vqRxIvZcd2ACiaA/132, createdBy=27552068432, createdName=kphysiotherapy, createdTime=Tue Sep 12 01:41:04 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1215517, encodeId=8c8a121551e42, content=审稿速度:2.0<br>经验分享:1/3月投稿,11/4大修,送外审中,比想象快一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Fri Apr 29 08:27:09 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127026, encodeId=240c212e02666, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:22.10.24投稿<br>一审2个审稿人;<br>分开两次送审;Awaiting initial access, with editor, under review;然后Awaiting initial access 再under review<br>22.12.28 大修<br>23.01.15 修回<br>23.04.04 Reject<br>一审编辑意见很积极,二审送的第3个独立的审稿人,最终被拒了。<br>审稿速度很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad912474377, createdName=12444cf9m16暂无昵称, createdTime=Wed Apr 19 14:50:34 CST 2023, time=2023-04-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1086043, encodeId=213c108604359, content=我为什么投了一个月/很长时间都没有消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220017, encodeId=cc4a122001e8a, content=投了快一个月了,催了两次,还在awaiting initial assessment,真是醉了......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbed2417119, createdName=1238add5m95(暂无昵称), createdTime=Mon May 16 14:14:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118326, encodeId=d132211832609, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:体验还行 历时4个多月 第一轮大修 第二轮小修 终于接收 编辑很友好 审稿人也很nice 不故意刁难 很感谢各方对我的帮助和宽容 这对我很重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Wed Mar 08 20:01:10 CST 2023, time=2023-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=509382, encodeId=63c250938245, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:SCI(2014):2.005 这个杂志实在是太慢了,急着毕业的同学们不要选择此杂志啊!刚中了一篇,跟大家分享一下进度吧! <br> 2014.2.12 投稿 <br> 2014.5月中旬催稿 <br> 2014.5.23 大修 <br> 2014.7.8 修回投稿 <br> 2014.9月初催稿 <br> 2014.9.19 小修 <br> 2014.9.22修回投稿 <br> 中间催稿2次 <br> 2014.12.1小修 <br> 2014.12.4修回投稿 <br> 2014.12.18接收 <br> 整个流程下来催稿催的好心酸啊!每次都是写给主编,副主编和责任编辑,主编很nice,会催下面的人,但是副主编回复都是应付事的,根本没什么作为,这个责任编辑就干脆不回复,最后主编告诉我说他和责任编辑沟通有点不畅,幸好最后接收了,但过程真心折磨人!催稿信一共写过6封!!!慎重啊!伙伴们!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a351612837, createdName=flair, createdTime=Mon Jan 26 14:58:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086044, encodeId=c2bc10860444b, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563036, encodeId=5c3a56303626, content=审稿速度:1.0<br>经验分享:一个Cohort,06-Aug-2018提交,30-Aug-2018 first decision Major Revision 改了将近两个月,在截止前 27-Oct-2018提交大修稿。 Accept 06-Nov-2018 人生第一篇SCI 两年多的心血,虽然分数不高,但是终于处女作要发表了。 AOGS给我印象挺好的,效率比之前评论高多了,而且态度很好很nice 看好这本杂志IF明年上3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/639d16c47afb4a52b6e1f3983790d196/154a00ea32344dbead810d8f723d8666.jpg, createdBy=eb382225597, createdName=12111381m06暂无昵称, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539944, encodeId=cef85399447f, content=有所上涨,看好未来,大家认为呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2023-04-19 12444cf9m16暂无昵称 来自北京

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:22.10.24投稿
    一审2个审稿人;
    分开两次送审;Awaiting initial access, with editor, under review;然后Awaiting initial access 再under review
    22.12.28 大修
    23.01.15 修回
    23.04.04 Reject
    一审编辑意见很积极,二审送的第3个独立的审稿人,最终被拒了。
    审稿速度很慢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2157230, encodeId=84e7215e2302c, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:3.22 投稿<br>6.13 大修<br>7.12 返修<br>7.20 大修<br>7.31 返修<br>8.10 大修<br>9.6 返修<br>9.9 小修<br>9.12 返修<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I4eex9tfQlPnDwV6Vtk58iaOrWVYVM62opN9yV2YbYHBfDialLcFgX8PymKecjib6NmgaHLcLs7vqRxIvZcd2ACiaA/132, createdBy=27552068432, createdName=kphysiotherapy, createdTime=Tue Sep 12 01:41:04 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1215517, encodeId=8c8a121551e42, content=审稿速度:2.0<br>经验分享:1/3月投稿,11/4大修,送外审中,比想象快一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Fri Apr 29 08:27:09 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127026, encodeId=240c212e02666, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:22.10.24投稿<br>一审2个审稿人;<br>分开两次送审;Awaiting initial access, with editor, under review;然后Awaiting initial access 再under review<br>22.12.28 大修<br>23.01.15 修回<br>23.04.04 Reject<br>一审编辑意见很积极,二审送的第3个独立的审稿人,最终被拒了。<br>审稿速度很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad912474377, createdName=12444cf9m16暂无昵称, createdTime=Wed Apr 19 14:50:34 CST 2023, time=2023-04-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1086043, encodeId=213c108604359, content=我为什么投了一个月/很长时间都没有消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220017, encodeId=cc4a122001e8a, content=投了快一个月了,催了两次,还在awaiting initial assessment,真是醉了......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbed2417119, createdName=1238add5m95(暂无昵称), createdTime=Mon May 16 14:14:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118326, encodeId=d132211832609, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:体验还行 历时4个多月 第一轮大修 第二轮小修 终于接收 编辑很友好 审稿人也很nice 不故意刁难 很感谢各方对我的帮助和宽容 这对我很重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Wed Mar 08 20:01:10 CST 2023, time=2023-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=509382, encodeId=63c250938245, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:SCI(2014):2.005 这个杂志实在是太慢了,急着毕业的同学们不要选择此杂志啊!刚中了一篇,跟大家分享一下进度吧! <br> 2014.2.12 投稿 <br> 2014.5月中旬催稿 <br> 2014.5.23 大修 <br> 2014.7.8 修回投稿 <br> 2014.9月初催稿 <br> 2014.9.19 小修 <br> 2014.9.22修回投稿 <br> 中间催稿2次 <br> 2014.12.1小修 <br> 2014.12.4修回投稿 <br> 2014.12.18接收 <br> 整个流程下来催稿催的好心酸啊!每次都是写给主编,副主编和责任编辑,主编很nice,会催下面的人,但是副主编回复都是应付事的,根本没什么作为,这个责任编辑就干脆不回复,最后主编告诉我说他和责任编辑沟通有点不畅,幸好最后接收了,但过程真心折磨人!催稿信一共写过6封!!!慎重啊!伙伴们!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a351612837, createdName=flair, createdTime=Mon Jan 26 14:58:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086044, encodeId=c2bc10860444b, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563036, encodeId=5c3a56303626, content=审稿速度:1.0<br>经验分享:一个Cohort,06-Aug-2018提交,30-Aug-2018 first decision Major Revision 改了将近两个月,在截止前 27-Oct-2018提交大修稿。 Accept 06-Nov-2018 人生第一篇SCI 两年多的心血,虽然分数不高,但是终于处女作要发表了。 AOGS给我印象挺好的,效率比之前评论高多了,而且态度很好很nice 看好这本杂志IF明年上3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/639d16c47afb4a52b6e1f3983790d196/154a00ea32344dbead810d8f723d8666.jpg, createdBy=eb382225597, createdName=12111381m06暂无昵称, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539944, encodeId=cef85399447f, content=有所上涨,看好未来,大家认为呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2021-12-28 rayms

    我为什么投了一个月/很长时间都没有消息?

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2157230, encodeId=84e7215e2302c, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:3.22 投稿<br>6.13 大修<br>7.12 返修<br>7.20 大修<br>7.31 返修<br>8.10 大修<br>9.6 返修<br>9.9 小修<br>9.12 返修<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I4eex9tfQlPnDwV6Vtk58iaOrWVYVM62opN9yV2YbYHBfDialLcFgX8PymKecjib6NmgaHLcLs7vqRxIvZcd2ACiaA/132, createdBy=27552068432, createdName=kphysiotherapy, createdTime=Tue Sep 12 01:41:04 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1215517, encodeId=8c8a121551e42, content=审稿速度:2.0<br>经验分享:1/3月投稿,11/4大修,送外审中,比想象快一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Fri Apr 29 08:27:09 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127026, encodeId=240c212e02666, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:22.10.24投稿<br>一审2个审稿人;<br>分开两次送审;Awaiting initial access, with editor, under review;然后Awaiting initial access 再under review<br>22.12.28 大修<br>23.01.15 修回<br>23.04.04 Reject<br>一审编辑意见很积极,二审送的第3个独立的审稿人,最终被拒了。<br>审稿速度很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad912474377, createdName=12444cf9m16暂无昵称, createdTime=Wed Apr 19 14:50:34 CST 2023, time=2023-04-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1086043, encodeId=213c108604359, content=我为什么投了一个月/很长时间都没有消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220017, encodeId=cc4a122001e8a, content=投了快一个月了,催了两次,还在awaiting initial assessment,真是醉了......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbed2417119, createdName=1238add5m95(暂无昵称), createdTime=Mon May 16 14:14:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118326, encodeId=d132211832609, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:体验还行 历时4个多月 第一轮大修 第二轮小修 终于接收 编辑很友好 审稿人也很nice 不故意刁难 很感谢各方对我的帮助和宽容 这对我很重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Wed Mar 08 20:01:10 CST 2023, time=2023-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=509382, encodeId=63c250938245, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:SCI(2014):2.005 这个杂志实在是太慢了,急着毕业的同学们不要选择此杂志啊!刚中了一篇,跟大家分享一下进度吧! <br> 2014.2.12 投稿 <br> 2014.5月中旬催稿 <br> 2014.5.23 大修 <br> 2014.7.8 修回投稿 <br> 2014.9月初催稿 <br> 2014.9.19 小修 <br> 2014.9.22修回投稿 <br> 中间催稿2次 <br> 2014.12.1小修 <br> 2014.12.4修回投稿 <br> 2014.12.18接收 <br> 整个流程下来催稿催的好心酸啊!每次都是写给主编,副主编和责任编辑,主编很nice,会催下面的人,但是副主编回复都是应付事的,根本没什么作为,这个责任编辑就干脆不回复,最后主编告诉我说他和责任编辑沟通有点不畅,幸好最后接收了,但过程真心折磨人!催稿信一共写过6封!!!慎重啊!伙伴们!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a351612837, createdName=flair, createdTime=Mon Jan 26 14:58:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086044, encodeId=c2bc10860444b, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563036, encodeId=5c3a56303626, content=审稿速度:1.0<br>经验分享:一个Cohort,06-Aug-2018提交,30-Aug-2018 first decision Major Revision 改了将近两个月,在截止前 27-Oct-2018提交大修稿。 Accept 06-Nov-2018 人生第一篇SCI 两年多的心血,虽然分数不高,但是终于处女作要发表了。 AOGS给我印象挺好的,效率比之前评论高多了,而且态度很好很nice 看好这本杂志IF明年上3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/639d16c47afb4a52b6e1f3983790d196/154a00ea32344dbead810d8f723d8666.jpg, createdBy=eb382225597, createdName=12111381m06暂无昵称, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539944, encodeId=cef85399447f, content=有所上涨,看好未来,大家认为呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2022-05-16 1238add5m95(暂无昵称)

    投了快一个月了,催了两次,还在awaiting initial assessment,真是醉了......

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2157230, encodeId=84e7215e2302c, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:3.22 投稿<br>6.13 大修<br>7.12 返修<br>7.20 大修<br>7.31 返修<br>8.10 大修<br>9.6 返修<br>9.9 小修<br>9.12 返修<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I4eex9tfQlPnDwV6Vtk58iaOrWVYVM62opN9yV2YbYHBfDialLcFgX8PymKecjib6NmgaHLcLs7vqRxIvZcd2ACiaA/132, createdBy=27552068432, createdName=kphysiotherapy, createdTime=Tue Sep 12 01:41:04 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1215517, encodeId=8c8a121551e42, content=审稿速度:2.0<br>经验分享:1/3月投稿,11/4大修,送外审中,比想象快一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Fri Apr 29 08:27:09 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127026, encodeId=240c212e02666, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:22.10.24投稿<br>一审2个审稿人;<br>分开两次送审;Awaiting initial access, with editor, under review;然后Awaiting initial access 再under review<br>22.12.28 大修<br>23.01.15 修回<br>23.04.04 Reject<br>一审编辑意见很积极,二审送的第3个独立的审稿人,最终被拒了。<br>审稿速度很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad912474377, createdName=12444cf9m16暂无昵称, createdTime=Wed Apr 19 14:50:34 CST 2023, time=2023-04-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1086043, encodeId=213c108604359, content=我为什么投了一个月/很长时间都没有消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220017, encodeId=cc4a122001e8a, content=投了快一个月了,催了两次,还在awaiting initial assessment,真是醉了......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbed2417119, createdName=1238add5m95(暂无昵称), createdTime=Mon May 16 14:14:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118326, encodeId=d132211832609, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:体验还行 历时4个多月 第一轮大修 第二轮小修 终于接收 编辑很友好 审稿人也很nice 不故意刁难 很感谢各方对我的帮助和宽容 这对我很重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Wed Mar 08 20:01:10 CST 2023, time=2023-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=509382, encodeId=63c250938245, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:SCI(2014):2.005 这个杂志实在是太慢了,急着毕业的同学们不要选择此杂志啊!刚中了一篇,跟大家分享一下进度吧! <br> 2014.2.12 投稿 <br> 2014.5月中旬催稿 <br> 2014.5.23 大修 <br> 2014.7.8 修回投稿 <br> 2014.9月初催稿 <br> 2014.9.19 小修 <br> 2014.9.22修回投稿 <br> 中间催稿2次 <br> 2014.12.1小修 <br> 2014.12.4修回投稿 <br> 2014.12.18接收 <br> 整个流程下来催稿催的好心酸啊!每次都是写给主编,副主编和责任编辑,主编很nice,会催下面的人,但是副主编回复都是应付事的,根本没什么作为,这个责任编辑就干脆不回复,最后主编告诉我说他和责任编辑沟通有点不畅,幸好最后接收了,但过程真心折磨人!催稿信一共写过6封!!!慎重啊!伙伴们!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a351612837, createdName=flair, createdTime=Mon Jan 26 14:58:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086044, encodeId=c2bc10860444b, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563036, encodeId=5c3a56303626, content=审稿速度:1.0<br>经验分享:一个Cohort,06-Aug-2018提交,30-Aug-2018 first decision Major Revision 改了将近两个月,在截止前 27-Oct-2018提交大修稿。 Accept 06-Nov-2018 人生第一篇SCI 两年多的心血,虽然分数不高,但是终于处女作要发表了。 AOGS给我印象挺好的,效率比之前评论高多了,而且态度很好很nice 看好这本杂志IF明年上3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/639d16c47afb4a52b6e1f3983790d196/154a00ea32344dbead810d8f723d8666.jpg, createdBy=eb382225597, createdName=12111381m06暂无昵称, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539944, encodeId=cef85399447f, content=有所上涨,看好未来,大家认为呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2023-03-08 hhyncgyzscygm 来自北京

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:临床
    经验分享:体验还行 历时4个多月 第一轮大修 第二轮小修 终于接收 编辑很友好 审稿人也很nice 不故意刁难 很感谢各方对我的帮助和宽容 这对我很重要

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2157230, encodeId=84e7215e2302c, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:3.22 投稿<br>6.13 大修<br>7.12 返修<br>7.20 大修<br>7.31 返修<br>8.10 大修<br>9.6 返修<br>9.9 小修<br>9.12 返修<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I4eex9tfQlPnDwV6Vtk58iaOrWVYVM62opN9yV2YbYHBfDialLcFgX8PymKecjib6NmgaHLcLs7vqRxIvZcd2ACiaA/132, createdBy=27552068432, createdName=kphysiotherapy, createdTime=Tue Sep 12 01:41:04 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1215517, encodeId=8c8a121551e42, content=审稿速度:2.0<br>经验分享:1/3月投稿,11/4大修,送外审中,比想象快一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Fri Apr 29 08:27:09 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127026, encodeId=240c212e02666, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:22.10.24投稿<br>一审2个审稿人;<br>分开两次送审;Awaiting initial access, with editor, under review;然后Awaiting initial access 再under review<br>22.12.28 大修<br>23.01.15 修回<br>23.04.04 Reject<br>一审编辑意见很积极,二审送的第3个独立的审稿人,最终被拒了。<br>审稿速度很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad912474377, createdName=12444cf9m16暂无昵称, createdTime=Wed Apr 19 14:50:34 CST 2023, time=2023-04-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1086043, encodeId=213c108604359, content=我为什么投了一个月/很长时间都没有消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220017, encodeId=cc4a122001e8a, content=投了快一个月了,催了两次,还在awaiting initial assessment,真是醉了......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbed2417119, createdName=1238add5m95(暂无昵称), createdTime=Mon May 16 14:14:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118326, encodeId=d132211832609, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:体验还行 历时4个多月 第一轮大修 第二轮小修 终于接收 编辑很友好 审稿人也很nice 不故意刁难 很感谢各方对我的帮助和宽容 这对我很重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Wed Mar 08 20:01:10 CST 2023, time=2023-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=509382, encodeId=63c250938245, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:SCI(2014):2.005 这个杂志实在是太慢了,急着毕业的同学们不要选择此杂志啊!刚中了一篇,跟大家分享一下进度吧! <br> 2014.2.12 投稿 <br> 2014.5月中旬催稿 <br> 2014.5.23 大修 <br> 2014.7.8 修回投稿 <br> 2014.9月初催稿 <br> 2014.9.19 小修 <br> 2014.9.22修回投稿 <br> 中间催稿2次 <br> 2014.12.1小修 <br> 2014.12.4修回投稿 <br> 2014.12.18接收 <br> 整个流程下来催稿催的好心酸啊!每次都是写给主编,副主编和责任编辑,主编很nice,会催下面的人,但是副主编回复都是应付事的,根本没什么作为,这个责任编辑就干脆不回复,最后主编告诉我说他和责任编辑沟通有点不畅,幸好最后接收了,但过程真心折磨人!催稿信一共写过6封!!!慎重啊!伙伴们!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a351612837, createdName=flair, createdTime=Mon Jan 26 14:58:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086044, encodeId=c2bc10860444b, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563036, encodeId=5c3a56303626, content=审稿速度:1.0<br>经验分享:一个Cohort,06-Aug-2018提交,30-Aug-2018 first decision Major Revision 改了将近两个月,在截止前 27-Oct-2018提交大修稿。 Accept 06-Nov-2018 人生第一篇SCI 两年多的心血,虽然分数不高,但是终于处女作要发表了。 AOGS给我印象挺好的,效率比之前评论高多了,而且态度很好很nice 看好这本杂志IF明年上3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/639d16c47afb4a52b6e1f3983790d196/154a00ea32344dbead810d8f723d8666.jpg, createdBy=eb382225597, createdName=12111381m06暂无昵称, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539944, encodeId=cef85399447f, content=有所上涨,看好未来,大家认为呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2015-01-26 flair

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享:SCI(2014):2.005 这个杂志实在是太慢了,急着毕业的同学们不要选择此杂志啊!刚中了一篇,跟大家分享一下进度吧!
    2014.2.12 投稿
    2014.5月中旬催稿
    2014.5.23 大修
    2014.7.8 修回投稿
    2014.9月初催稿
    2014.9.19 小修
    2014.9.22修回投稿
    中间催稿2次
    2014.12.1小修
    2014.12.4修回投稿
    2014.12.18接收
    整个流程下来催稿催的好心酸啊!每次都是写给主编,副主编和责任编辑,主编很nice,会催下面的人,但是副主编回复都是应付事的,根本没什么作为,这个责任编辑就干脆不回复,最后主编告诉我说他和责任编辑沟通有点不畅,幸好最后接收了,但过程真心折磨人!催稿信一共写过6封!!!慎重啊!伙伴们!

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2157230, encodeId=84e7215e2302c, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:3.22 投稿<br>6.13 大修<br>7.12 返修<br>7.20 大修<br>7.31 返修<br>8.10 大修<br>9.6 返修<br>9.9 小修<br>9.12 返修<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I4eex9tfQlPnDwV6Vtk58iaOrWVYVM62opN9yV2YbYHBfDialLcFgX8PymKecjib6NmgaHLcLs7vqRxIvZcd2ACiaA/132, createdBy=27552068432, createdName=kphysiotherapy, createdTime=Tue Sep 12 01:41:04 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1215517, encodeId=8c8a121551e42, content=审稿速度:2.0<br>经验分享:1/3月投稿,11/4大修,送外审中,比想象快一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Fri Apr 29 08:27:09 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127026, encodeId=240c212e02666, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:22.10.24投稿<br>一审2个审稿人;<br>分开两次送审;Awaiting initial access, with editor, under review;然后Awaiting initial access 再under review<br>22.12.28 大修<br>23.01.15 修回<br>23.04.04 Reject<br>一审编辑意见很积极,二审送的第3个独立的审稿人,最终被拒了。<br>审稿速度很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad912474377, createdName=12444cf9m16暂无昵称, createdTime=Wed Apr 19 14:50:34 CST 2023, time=2023-04-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1086043, encodeId=213c108604359, content=我为什么投了一个月/很长时间都没有消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220017, encodeId=cc4a122001e8a, content=投了快一个月了,催了两次,还在awaiting initial assessment,真是醉了......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbed2417119, createdName=1238add5m95(暂无昵称), createdTime=Mon May 16 14:14:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118326, encodeId=d132211832609, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:体验还行 历时4个多月 第一轮大修 第二轮小修 终于接收 编辑很友好 审稿人也很nice 不故意刁难 很感谢各方对我的帮助和宽容 这对我很重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Wed Mar 08 20:01:10 CST 2023, time=2023-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=509382, encodeId=63c250938245, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:SCI(2014):2.005 这个杂志实在是太慢了,急着毕业的同学们不要选择此杂志啊!刚中了一篇,跟大家分享一下进度吧! <br> 2014.2.12 投稿 <br> 2014.5月中旬催稿 <br> 2014.5.23 大修 <br> 2014.7.8 修回投稿 <br> 2014.9月初催稿 <br> 2014.9.19 小修 <br> 2014.9.22修回投稿 <br> 中间催稿2次 <br> 2014.12.1小修 <br> 2014.12.4修回投稿 <br> 2014.12.18接收 <br> 整个流程下来催稿催的好心酸啊!每次都是写给主编,副主编和责任编辑,主编很nice,会催下面的人,但是副主编回复都是应付事的,根本没什么作为,这个责任编辑就干脆不回复,最后主编告诉我说他和责任编辑沟通有点不畅,幸好最后接收了,但过程真心折磨人!催稿信一共写过6封!!!慎重啊!伙伴们!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a351612837, createdName=flair, createdTime=Mon Jan 26 14:58:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086044, encodeId=c2bc10860444b, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563036, encodeId=5c3a56303626, content=审稿速度:1.0<br>经验分享:一个Cohort,06-Aug-2018提交,30-Aug-2018 first decision Major Revision 改了将近两个月,在截止前 27-Oct-2018提交大修稿。 Accept 06-Nov-2018 人生第一篇SCI 两年多的心血,虽然分数不高,但是终于处女作要发表了。 AOGS给我印象挺好的,效率比之前评论高多了,而且态度很好很nice 看好这本杂志IF明年上3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/639d16c47afb4a52b6e1f3983790d196/154a00ea32344dbead810d8f723d8666.jpg, createdBy=eb382225597, createdName=12111381m06暂无昵称, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539944, encodeId=cef85399447f, content=有所上涨,看好未来,大家认为呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2021-12-29 MS68862005

    期刊的审稿时间一般是多久?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2157230, encodeId=84e7215e2302c, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:3.22 投稿<br>6.13 大修<br>7.12 返修<br>7.20 大修<br>7.31 返修<br>8.10 大修<br>9.6 返修<br>9.9 小修<br>9.12 返修<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I4eex9tfQlPnDwV6Vtk58iaOrWVYVM62opN9yV2YbYHBfDialLcFgX8PymKecjib6NmgaHLcLs7vqRxIvZcd2ACiaA/132, createdBy=27552068432, createdName=kphysiotherapy, createdTime=Tue Sep 12 01:41:04 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1215517, encodeId=8c8a121551e42, content=审稿速度:2.0<br>经验分享:1/3月投稿,11/4大修,送外审中,比想象快一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Fri Apr 29 08:27:09 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127026, encodeId=240c212e02666, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:22.10.24投稿<br>一审2个审稿人;<br>分开两次送审;Awaiting initial access, with editor, under review;然后Awaiting initial access 再under review<br>22.12.28 大修<br>23.01.15 修回<br>23.04.04 Reject<br>一审编辑意见很积极,二审送的第3个独立的审稿人,最终被拒了。<br>审稿速度很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad912474377, createdName=12444cf9m16暂无昵称, createdTime=Wed Apr 19 14:50:34 CST 2023, time=2023-04-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1086043, encodeId=213c108604359, content=我为什么投了一个月/很长时间都没有消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220017, encodeId=cc4a122001e8a, content=投了快一个月了,催了两次,还在awaiting initial assessment,真是醉了......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbed2417119, createdName=1238add5m95(暂无昵称), createdTime=Mon May 16 14:14:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118326, encodeId=d132211832609, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:体验还行 历时4个多月 第一轮大修 第二轮小修 终于接收 编辑很友好 审稿人也很nice 不故意刁难 很感谢各方对我的帮助和宽容 这对我很重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Wed Mar 08 20:01:10 CST 2023, time=2023-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=509382, encodeId=63c250938245, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:SCI(2014):2.005 这个杂志实在是太慢了,急着毕业的同学们不要选择此杂志啊!刚中了一篇,跟大家分享一下进度吧! <br> 2014.2.12 投稿 <br> 2014.5月中旬催稿 <br> 2014.5.23 大修 <br> 2014.7.8 修回投稿 <br> 2014.9月初催稿 <br> 2014.9.19 小修 <br> 2014.9.22修回投稿 <br> 中间催稿2次 <br> 2014.12.1小修 <br> 2014.12.4修回投稿 <br> 2014.12.18接收 <br> 整个流程下来催稿催的好心酸啊!每次都是写给主编,副主编和责任编辑,主编很nice,会催下面的人,但是副主编回复都是应付事的,根本没什么作为,这个责任编辑就干脆不回复,最后主编告诉我说他和责任编辑沟通有点不畅,幸好最后接收了,但过程真心折磨人!催稿信一共写过6封!!!慎重啊!伙伴们!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a351612837, createdName=flair, createdTime=Mon Jan 26 14:58:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086044, encodeId=c2bc10860444b, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563036, encodeId=5c3a56303626, content=审稿速度:1.0<br>经验分享:一个Cohort,06-Aug-2018提交,30-Aug-2018 first decision Major Revision 改了将近两个月,在截止前 27-Oct-2018提交大修稿。 Accept 06-Nov-2018 人生第一篇SCI 两年多的心血,虽然分数不高,但是终于处女作要发表了。 AOGS给我印象挺好的,效率比之前评论高多了,而且态度很好很nice 看好这本杂志IF明年上3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/639d16c47afb4a52b6e1f3983790d196/154a00ea32344dbead810d8f723d8666.jpg, createdBy=eb382225597, createdName=12111381m06暂无昵称, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539944, encodeId=cef85399447f, content=有所上涨,看好未来,大家认为呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2018-11-10 12111381m06暂无昵称

    审稿速度:1.0
    经验分享:一个Cohort,06-Aug-2018提交,30-Aug-2018 first decision Major Revision 改了将近两个月,在截止前 27-Oct-2018提交大修稿。 Accept 06-Nov-2018 人生第一篇SCI 两年多的心血,虽然分数不高,但是终于处女作要发表了。 AOGS给我印象挺好的,效率比之前评论高多了,而且态度很好很nice 看好这本杂志IF明年上3

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2157230, encodeId=84e7215e2302c, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:3.22 投稿<br>6.13 大修<br>7.12 返修<br>7.20 大修<br>7.31 返修<br>8.10 大修<br>9.6 返修<br>9.9 小修<br>9.12 返修<br>等待中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/I4eex9tfQlPnDwV6Vtk58iaOrWVYVM62opN9yV2YbYHBfDialLcFgX8PymKecjib6NmgaHLcLs7vqRxIvZcd2ACiaA/132, createdBy=27552068432, createdName=kphysiotherapy, createdTime=Tue Sep 12 01:41:04 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1215517, encodeId=8c8a121551e42, content=审稿速度:2.0<br>经验分享:1/3月投稿,11/4大修,送外审中,比想象快一点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=722f2896174, createdName=pinger3557219, createdTime=Fri Apr 29 08:27:09 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127026, encodeId=240c212e02666, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:22.10.24投稿<br>一审2个审稿人;<br>分开两次送审;Awaiting initial access, with editor, under review;然后Awaiting initial access 再under review<br>22.12.28 大修<br>23.01.15 修回<br>23.04.04 Reject<br>一审编辑意见很积极,二审送的第3个独立的审稿人,最终被拒了。<br>审稿速度很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad912474377, createdName=12444cf9m16暂无昵称, createdTime=Wed Apr 19 14:50:34 CST 2023, time=2023-04-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1086043, encodeId=213c108604359, content=我为什么投了一个月/很长时间都没有消息?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220017, encodeId=cc4a122001e8a, content=投了快一个月了,催了两次,还在awaiting initial assessment,真是醉了......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbed2417119, createdName=1238add5m95(暂无昵称), createdTime=Mon May 16 14:14:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118326, encodeId=d132211832609, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:体验还行 历时4个多月 第一轮大修 第二轮小修 终于接收 编辑很友好 审稿人也很nice 不故意刁难 很感谢各方对我的帮助和宽容 这对我很重要, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29d92145193, createdName=hhyncgyzscygm, createdTime=Wed Mar 08 20:01:10 CST 2023, time=2023-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=509382, encodeId=63c250938245, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:SCI(2014):2.005 这个杂志实在是太慢了,急着毕业的同学们不要选择此杂志啊!刚中了一篇,跟大家分享一下进度吧! <br> 2014.2.12 投稿 <br> 2014.5月中旬催稿 <br> 2014.5.23 大修 <br> 2014.7.8 修回投稿 <br> 2014.9月初催稿 <br> 2014.9.19 小修 <br> 2014.9.22修回投稿 <br> 中间催稿2次 <br> 2014.12.1小修 <br> 2014.12.4修回投稿 <br> 2014.12.18接收 <br> 整个流程下来催稿催的好心酸啊!每次都是写给主编,副主编和责任编辑,主编很nice,会催下面的人,但是副主编回复都是应付事的,根本没什么作为,这个责任编辑就干脆不回复,最后主编告诉我说他和责任编辑沟通有点不畅,幸好最后接收了,但过程真心折磨人!催稿信一共写过6封!!!慎重啊!伙伴们!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a351612837, createdName=flair, createdTime=Mon Jan 26 14:58:00 CST 2015, time=2015-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086044, encodeId=c2bc10860444b, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563036, encodeId=5c3a56303626, content=审稿速度:1.0<br>经验分享:一个Cohort,06-Aug-2018提交,30-Aug-2018 first decision Major Revision 改了将近两个月,在截止前 27-Oct-2018提交大修稿。 Accept 06-Nov-2018 人生第一篇SCI 两年多的心血,虽然分数不高,但是终于处女作要发表了。 AOGS给我印象挺好的,效率比之前评论高多了,而且态度很好很nice 看好这本杂志IF明年上3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/639d16c47afb4a52b6e1f3983790d196/154a00ea32344dbead810d8f723d8666.jpg, createdBy=eb382225597, createdName=12111381m06暂无昵称, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539944, encodeId=cef85399447f, content=有所上涨,看好未来,大家认为呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2017-07-18 yang_guoqiang2010

    有所上涨,看好未来,大家认为呢?

    0

共33条页码: 1/4页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分